• 1. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 2. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 3. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 4. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

Introduction to Nonadecanoic Acid 3-(Acetyloxy)-2-hydroxypropyl Ester (CAS No: 120602-61-1)

Nonadecanoic Acid 3-(Acetyloxy)-2-hydroxypropyl Ester, a compound with the chemical identifier CAS No: 120602-61-1, is a specialized chemical entity that has garnered significant attention in the field of pharmaceuticals and biotechnology. This compound, characterized by its unique molecular structure, exhibits promising properties that make it a valuable candidate for various applications, particularly in drug formulation and bioactive molecule synthesis.

The molecular structure of Nonadecanoic Acid 3-(Acetyloxy)-2-hydroxypropyl Ester consists of a nonadecanoic acid backbone modified with an acetyloxy group at the 3-position and a hydroxylpropyl group at the 2-position. This specific arrangement imparts unique physicochemical properties, such as solubility and stability, which are critical for its utility in pharmaceutical formulations. The presence of both hydrophilic and lipophilic moieties enhances its compatibility with diverse biological systems, making it an attractive candidate for drug delivery systems and bioavailability enhancement.

In recent years, there has been a surge in research focused on developing novel drug delivery systems that can improve the efficacy and reduce the side effects of therapeutic agents. Nonadecanoic Acid 3-(Acetyloxy)-2-hydroxypropyl Ester has emerged as a key component in the design of advanced drug carriers. Its ability to form stable complexes with hydrophobic drugs while maintaining good solubility in aqueous environments makes it an ideal candidate for oral and parenteral drug delivery formulations. Furthermore, its structural features allow for controlled release mechanisms, which can be tailored to achieve optimal therapeutic outcomes.

The pharmaceutical industry has been increasingly interested in exploring the potential of Nonadecanoic Acid 3-(Acetyloxy)-2-hydroxypropyl Ester as an excipient in drug formulations. Excipients play a crucial role in ensuring the stability, bioavailability, and patient compliance of pharmaceutical products. This compound's unique properties make it suitable for enhancing the solubility of poorly water-soluble drugs, thereby improving their absorption and distribution within the body. Such advancements are particularly significant in the treatment of diseases where drug solubility is a major limiting factor.

Moreover, recent studies have highlighted the potential applications of Nonadecanoic Acid 3-(Acetyloxy)-2-hydroxypropyl Ester in the field of regenerative medicine. Its ability to promote cell adhesion and proliferation makes it a promising candidate for tissue engineering applications. Researchers have been exploring its use as a scaffold material or as an additive to enhance the performance of biomaterials used in tissue regeneration. The compound's biocompatibility and ability to support cellular interactions make it a valuable asset in developing innovative therapeutic strategies.

In addition to its pharmaceutical applications, Nonadecanoic Acid 3-(Acetyloxy)-2-hydroxypropyl Ester has shown potential in industrial applications as well. Its unique chemical properties make it suitable for use as an intermediate in the synthesis of various specialty chemicals and polymers. The compound's ability to undergo selective reactions while maintaining structural integrity makes it a valuable building block for complex chemical transformations. This versatility has opened up new avenues for research and development in industrial chemistry.

The synthesis of Nonadecanoic Acid 3-(Acetyloxy)-2-hydroxypropyl Ester is another area of active research. Chemists have been working on optimizing synthetic routes to produce this compound efficiently and cost-effectively. Advances in synthetic methodologies have enabled the production of high-purity batches of this compound, which are essential for its application in sensitive pharmaceutical formulations. The development of greener synthetic methods is also a focus area, aiming to minimize environmental impact while maintaining high yields and purity.

The safety profile of Nonadecanoic Acid 3-(Acetyloxy)-2-hydroxypropyl Ester is another critical aspect that has been extensively studied. Preclinical studies have demonstrated its low toxicity profile, making it suitable for use in various biological systems without significant adverse effects. However, further research is needed to fully understand its long-term safety implications. Continuous monitoring and evaluation are essential to ensure that this compound remains safe and effective for its intended applications.

In conclusion, Nonadecanoic Acid 3-(Acetyloxy)-2-hydroxypropyl Ester (CAS No: 120602-61-1) is a multifaceted compound with significant potential in pharmaceuticals, biotechnology, and industrial chemistry. Its unique molecular structure and physicochemical properties make it an invaluable asset in drug formulation, tissue engineering, and specialty chemical synthesis. As research continues to uncover new applications and optimize synthetic methods, this compound is poised to play an increasingly important role in advancing scientific and medical innovations.

• 123-94-4(Monostearin)
• 60456-26-0([(2R)-oxiran-2-yl]methyl butanoate)
• 65381-09-1(Caprylic/Capric Triglyceride)
• 9005-66-7(Polysorbate 40)
• 555-44-2(Tripalmitin)
• 555-43-1(Tristearin)
• 1338-39-2(Sorbitan Monolaurate)
• 1338-41-6(Span 60)
• 9005-64-5(Polysorbate 20)
• 9005-67-8(Tween 60)